Botulinum Toxin Market Size By Product (Botulinum Toxin A, Botulinum Toxin B), By Application (Medical, Aesthetic), By Gender (Female, Male), By Age Group (13-19, 20-29, 30-39, 40-54, 55 and Above), By End-use (Hospitals, Dermatology Clinics, Spas & Cosmetic Centers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Jun 2019  |  Report ID: GMI3408  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 160   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Botulinum Toxin Market size was valued at USD 4.7 billion in 2018 and is expected to witness more than 9.1% CAGR from 2019 to 2025. Increase in the prevalence of cervical dystonia and spasticity as well as number of cases of chronic migraine is expected to boost market growth during the forecast period. Moreover, surge in adoption rate of non-surgical botulinum toxin procedures, due to their minimally invasive or non-invasive nature, is augmenting market demand over the forecast timeframe.
 

Botulinum Toxin Market

Get more details on this report - Request Free Sample PDF
 

Botulinum toxin is widely used in the treatment of various aging signs such as frown lines, forehead lines, square jaws, crow's feet and others. Moreover, rising number of manufacturers in various economies will further augment the market growth. Hence, growing influence of aesthetics among the population coupled with increasing number of manufacturers of various developed and developing countries will further propel industry growth.
 

However, side effects such as rash, allergic reactions, back and neck pain, nausea and shortness of breath are hindering the adoption rate of botulinum toxin in aesthetic as well as therapeutic application. Additionally, poor reimbursement coverage for such procedures are further hampering market growth.
 

Botulinum Toxin Market Report Coverage
Report Coverage Details
Base Year: 2018 Market Size in 2018: 4723.6 Million (USD)
Historical Data for: 2014 to 2018 Forecast Period: 2019 to 2025
Forecast Period 2019 to 2025 CAGR: 9.1% 2025 Value Projection: 8.5 Billion (USD)
Pages: 160 Tables, Charts & Figures: 294
Geographies covered (18): U.S., Canada, Germany, UK, France, Spain, Italy, Turkey, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Egypt, Iran
Segments covered: Product, Application, Gender, Age Group, End-use and Region
Companies covered (9): Allergan, Eisai Co. Ltd., Galderma S.A., Hugel, Inc., Hugh source international Ltd., Ipsen, Medytox, Inc., Merz Pharma, Revance Therapeutics, Inc.

Get more details on this report - Request Free Sample PDF
 

By Product

Germany botulinum toxin market

Get more details on this report - Request Free Sample PDF
 

Botulinum toxin A market accounted for a total value of USD 3.32 billion in 2018 and is expected to grow at a robust growth rate owing to rise in interest of manufacturers in development of such products. High demand for botulinum toxin A and growing application in various aesthetic and medical fields will also drive the market demand. Allergan is one of the major manufacturers of botulinum toxin A and holds the highest market share in 2018. Moreover, growing adoption of non-invasive aesthetic procedures will contribute to market growth.
 

Botulinum toxin B is expected to witness considerable growth in the over 2019 to 2025 owing to rise in number of FDA approvals of novel botulinum toxin products for different indications. Additionally, growing incidence of spasticity among the geriatric population coupled with increasing prevalence of neurological disorders will also boost product demand.
 

By Application

Medical application accounted 57.3% market share in 2018. Growing prevalence of spasticity and cervical dystonia coupled with increasing incidence of migraine will propel medical botulinum toxin market expansion. Additionally, increasing capital investments for research and development of such products will further augment industry growth. 
 

Aesthetic application is expected to expand at 8.4% CAGR during 2019 to 2025. Botulinum toxin is predominantly used as a treatment to reduce the appearance of fine lines and facial wrinkles. Rising awareness about various cosmetic procedures to reduce various signs of ageing, specifically in women will boost the product demand.
 

By Gender

Females dominate the botulinum toxin market and accounted for a total value of USD 4.4 billion in the year 2018. Moreover, rising trends in middle-aged women to stay young have boosted the product demand. Ageing signs such as frown lines, forehead lines, crow's feet etc. can be reduced with botulinum toxin procedures.
 

Most people seek out for a botulinum toxin treatment owing to its age-reversing effects. Male segment is expected to grow at 10.4% through 2025. Botulinum toxin is known as a neuromodulator that reduces the speed of ageing. Rising minimally invasive procedures coupled with growing trends in males to look pleasant and young have augmented the growth of the market.
 

By Age Group

People between the age of 30-39 years tend to opt for various botox procedures and is expected to witness a robust growth of 9.6% over 2019 to 2025. Rising awareness among people about various cosmetic procedures coupled with major influence of social media on changing beauty trends will further propel the segment growth.
 

Botulinum toxin procedures are growing at a robust rate among the middle-aged population. People between the age group of 40-54 years generated maximum revenue of USD 2,649.6 million in 2018. Factors such as rising signs of ageing, increasing awareness about various aesthetic procedures and growing disposable income are the major factors augmenting the segment growth.
 

By End-use

Dermatological clinics segment generated maximum revenue of USD 2.2 billion in 2018. Moreover, people prefer dermatological clinics over any other settings for such procedures due to availability of state-of-the-art facilities.
 

Spas and cosmetic centers segment is forecast to expand at 9.5% CAGR from 2019 to 2025. Growing trends of minimally invasive aesthetic surgeries coupled with increasing number of spas and cosmetic centers in developed and developing economies will render positive effect on the segmental growth. 
 

By Region

Europe Botulinum Toxin Market

Get more details on this report - Request Free Sample PDF
 

U.S. botulinum toxin market was valued at 3.3 billion in 2018. Presence of major industry players including Allergan will significantly drive the U.S. market. Moreover, rising prevalence of medical conditions such blepharospasm, cervical dystonia, chronic migraine and severe primary axillary hyperhidrosis will show a positive growth trajectory over the forecast period. Additionally, rising influence of social media about latest beauty trends specifically in developed regions will augment industry growth.
 

China is estimated to exhibit a significant growth of 11.2% during the forecast period due to rising geriatric population that are more prone to chronic muscle spasticity and acute migraine syndromes. Furthermore, growing trends among the millennials about various aesthetic procedures will drive market demand. 
 

Competitive Market Share

Few of the notable players operating in global botulinum toxin market share are Allergan, Eisai Co., Ltd., Galderma S.A., Hugel Inc., Hugh source international ltd., Ipsen, Medytox Inc., Merz Pharma and Revance Therapeutics, Inc. These industry players implemented various strategies such as mergers and acquisitions, collaborations, new product launch, etc. in order to capture high revenues.
 

Botulinum toxin industry research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD billion from 2014 to 2025, for the following segments: 

By Product, 2014 – 2025 (USD Billion)

  • Botulinum toxin A
  • Botulinum toxin B

By Application, 2014 – 2025 (USD Billion)

  • Medical
  • Aesthetic

By Gender, 2014 – 2025 (USD Billion)

  • Female
  • Male

By Age Group, 2014 – 2025 (USD Billion)

  • 13-19
  • 20-29
  • 30-39
  • 40-54
  • 55 and above

By End-Use, 2014 – 2025 (USD Billion)

  • Hospitals
  • Dermatology clinics
  • Spas & cosmetic centers

The above information is provided for the following regions/countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Turkey
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa
    • Egypt
    • Iran

 

Frequently Asked Questions (FAQ) :

Botulinum toxin is widely in various cosmetic procedures for treating aging signs like frown lines, forehead lines, square jaws, crow's feet, and also for reducing the appearance of fine lines and facial wrinkles.
Side effects such as rash, back and neck pain, allergic reactions, nausea and shortness of breath are likely to be encountered following botulinum toxin use.
Rise in cases of spasticity and cervical dystonia, increase in incidence of migraine and pumping capital investments in R&D activities may supplement the medical botulinum toxin industry size.
A notable surge in prevalence of medical conditions like blepharospasm, chronic migraine, cervical dystonia, and severe primary axillary hyperhidrosis have propelled the demand for botulinum toxin in the U.S.

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Jun 2019
  • Pages: 160
  • Tables: 284
  • Charts / Figures: 10
  • Companies covered: 9
  • Countries covered: 18

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X